Iovance Biotherapeutics, Inc. (IOVA) Analyst Estimates Quarterly

Iovance Biotherapeutics, Inc.

IOVA (NASDAQ)

(%)

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2026 12-30	2025 09-30	2025 06-30	2025 03-30	2024 12-30	2024 09-30	2024 06-30	2024 03-30	2023 12-30	2023 09-30	2023 06-30	2023 03-31
Number of Analysts	1234	7	11	7	9	9	9	9	8	4	6	4
Estimated Revenue
Low	1234	68.04	55.13	76.54	69.84	53.24	5.66	0.336	0.565	3.84	3.91	0.199
Average	1234	72.85	67.1	82.37	72.11	53.79	24.59	2.03	1.44	4.5	3.91	0.222
High	1234	77.42	75.86	87.79	77.91	54.46	39.88	4.2	2.31	5.4	3.91	0.274
Estimated EBITDA
Low	1234	13.61	11.03	15.31	13.97	10.65	1.13	0.067	0.113	0.768	0.782	0.04
Average	1234	14.57	13.42	16.47	14.42	10.76	4.92	0.406	0.288	0.9	0.782	0.044
High	1234	15.48	15.17	17.56	15.58	10.89	7.98	0.84	0.461	1.08	0.782	0.055
Estimated EBIT
Low	1234	13.61	11.03	15.31	13.97	10.65	1.13	0.067	0.113	0.768	0.782	0.04
Average	1234	14.57	13.42	16.47	14.42	10.76	4.92	0.406	0.288	0.9	0.782	0.044
High	1234	15.48	15.17	17.56	15.58	10.89	7.98	0.84	0.461	1.08	0.782	0.055
Estimated Net Income
Low	1234	-89.17	-116.3	-96.41	-99.5	-112.9	-140.6	-157.7	-153.9	-191.5	-160.9	-214.5
Average	1234	-86.19	-94.59	-80.86	-89.55	-99.97	-118.2	-141.9	-144.1	-152.1	-160.9	-164.4
High	1234	-83.22	-75.28	-68.42	-82.92	-80.62	-105.5	-126.2	-131	-123	-160.9	-142.2
Estimated SGA Expenses
Low	1234	1,277	1,035	1,437	1,311	999.4	106.3	6.3	10.6	72.04	73.38	3.74
Average	1234	1,367	1,260	1,546	1,354	1,010	461.7	38.09	27.05	84.47	73.38	4.17
High	1234	1,453	1,424	1,648	1,462	1,022	748.6	78.8	43.27	101.3	73.38	5.15
Estimated EPS
Low	1234	-0.267	-0.348	-0.288	-0.297	-0.337	-0.42	-0.471	-0.46	-0.572	-0.498	-0.74
Average	1234	-0.258	-0.283	-0.242	-0.268	-0.299	-0.353	-0.424	-0.431	-0.455	-0.498	-0.567
High	1234	-0.249	-0.225	-0.205	-0.248	-0.241	-0.315	-0.377	-0.392	-0.368	-0.498	-0.491

Market is Open